Exosome Quality Control Platform

The Exosome Quality Control Platform is a dedicated analytical service layer beyond manufacturing workflow testing, focused on method selection, orthogonal evidence, product understanding, process comparison, functional correlation and data interpretation.

Quick Facts

  • Basic Characterization & EV Identity: Confirm EV-associated morphology, particle features, markers and physicochemical attributes.
  • Purity, Membrane Integrity & Impurity Analysis: Evaluate effective membrane-bound particles, non-vesicular background and process-related impurities.
  • Source Identity & Molecular Component Analysis: Assess source-related identity, active cargos and engineered payload presentation.
  • Functional Bioactivity & Potency Evaluation: Connect product attributes with biological response through normalized functional models.
  • Safety & Pharmacopeia-Related Quality Testing: Assess microbiological control, physicochemical attributes and formulation-related quality risks.
  • Exosome Proteomics & RNA Omics: Support discovery and validation of differential cargos, pathways and candidate molecules.

Platform Positioning

The Exosome Quality Control Platform is a dedicated analytical service layer beyond manufacturing workflow testing, focused on method selection, orthogonal evidence, product understanding, process comparison, functional correlation and data interpretation.

Compared with manufacturing analytics, this platform emphasizes multi-resolution evidence, project-specific analytical strategy and integrated analytical packages.

Core Analytical Modules

Basic Characterization & EV Identity: TEM, NTA, RPS, DLS, Western blot, ELISA, Zeta potential and related methods confirm EV-associated morphology, particle features and physicochemical attributes.

Purity, Membrane Integrity & Impurity Analysis: HPLC-SEC, particle/protein ratio, membrane-integrity assays, host-cell protein or nucleic acid and non-vesicular impurity analysis evaluate intact EV material and background.

Source Identity & Molecular Component Analysis: source-related proteins, MSC-EV specific markers, target-positive particles, qPCR or ddPCR and cargo quantification evaluate source identity and cargo consistency.

Functional Bioactivity & Potency Evaluation: cell-based potency models, dose-response curves, anti-inflammatory or repair-related readouts and mechanism-related markers connect product attributes with biological response.

Safety & Pharmacopeia-Related Quality Testing: sterility, mycoplasma, endotoxin, pH, osmolality and particulate matter evaluate microbiological control and formulation-related attributes.

Exosome Proteomics & RNA Omics: proteomics and RNA sequencing support differential cargo discovery, mechanism exploration, condition comparison and prioritization of biomarkers or functional candidates.

Evidence Perspectives and Omics

The same EV sample can be examined through bulk analytics, single-particle analytics, functional analytics and systems-level omics to reduce over-interpretation of any single readout.

Exosome proteomics characterizes membrane and luminal proteins for differential protein analysis, functional enrichment and EV-database comparison.

Exosome RNA omics can include small RNA, miRNA, long RNA, mRNA, lncRNA and optional circRNA analysis with qPCR validation of prioritized candidates.

Workflow and Deliverables

The workflow covers defining the question, assessing sample fit, designing the panel, running and controlling assays, integrating data and supporting next steps.

Representative deliverables include a technical plan, raw data, figures, interpretive report and next-step options.

Scope and Limitations

The platform supports research, process development, preclinical and translational-development programs. Final methods, sample requirements, study design, timelines, specifications and regulatory suitability are confirmed through project-specific technical assessment.

Services and outputs described here are not intended for direct diagnosis or direct clinical use.

FAQ

What does the Exosome Quality Control Platform page cover?
Exosome Quality Control Platform is an Echo Biotech technology platform page. The Exosome Quality Control Platform is a dedicated analytical service layer beyond manufacturing workflow testing, focused on method selection, orthogonal evidence, product understanding, process comparison, functional correlation and data interpretation.
What directions are included under Exosome Quality Control Platform?
This page includes directions such as Basic Characterization & EV Identity, Purity, Membrane Integrity & Impurity Analysis, Source Identity & Molecular Component Analysis, Functional Bioactivity & Potency Evaluation, Safety & Pharmacopeia-Related Quality Testing, and Exosome Proteomics & RNA Omics.
How can customers learn more about Exosome Quality Control Platform?
Customers can open the related detail pages for specific information or contact Echo Biotech to confirm specifications, sample requirements, service workflows, or collaboration options.